Cargando…
Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease
Hematopoietic allogeneic stem cell transplantation (allo-SCT) is a curative option for patients with hematological malignancies. However, due to disparities in major and minor histocompatibility antigens between donor and recipient, severe inflammatory complications can occur, among which chronic gr...
Autores principales: | Doglio, Matteo, Crossland, Rachel E., Alho, Ana C., Penack, Olaf, Dickinson, Anne M., Stary, Georg, Lacerda, João F., Eissner, Günther, Inngjerdingen, Marit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714556/ https://www.ncbi.nlm.nih.gov/pubmed/36466922 http://dx.doi.org/10.3389/fimmu.2022.1045168 |
Ejemplares similares
-
Complex interactions of cellular players in chronic Graft-versus-Host Disease
por: Gail, Laura Marie, et al.
Publicado: (2023) -
Tissue-Specific Expression Patterns of MicroRNA during Acute Graft-versus-Host Disease in the Rat
por: Jalapothu, Dasaradha, et al.
Publicado: (2016) -
Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020) -
New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions
por: Saidu, Nathaniel Edward Bennett, et al.
Publicado: (2020) -
Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)